Penelope-georgia Papayanni
Thessaloniki, ESYE12, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial.
Journal: Nature medicine
Published: November 04, 2022
Case study of betibeglogene autotemcel gene therapy in an adult Greek patient with transfusion-dependent β-thalassaemia of a severe genotype.
Journal: British journal of haematology
Published: November 02, 2021
Investigating the Barrier Activity of Novel, Human Enhancer-Blocking Chromatin Insulators for Hematopoietic Stem Cell Gene Therapy.
Journal: Human gene therapy
Published: September 03, 2021
Vaccinated and Convalescent Donor-Derived Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 05, 2021
"Cerberus" T Cells: A Glucocorticoid-Resistant, Multi-Pathogen Specific T Cell Product to Fight Infections in Severely Immunocompromised Patients.
Journal: Frontiers in immunology
Published: September 21, 2020
Non-transplantable cord blood units as a source for adoptive immunotherapy of leukaemia and a paradigm of circular economy in medicine.
Journal: British journal of haematology
Published: January 08, 2020
The Functional Effect of Repeated Cryopreservation on Transduced CD34+ Cells from Patients with Thalassemia.
Journal: Human gene therapy methods
Published: August 07, 2018
A New Era for Hemoglobinopathies: More Than One Curative Option.
Journal: Current gene therapy
Published: September 09, 2017
Poor stem cell harvest may not always be related to poor mobilization: lessons gained from a mobilization study in patients with β-thalassemia major.
Journal: Transfusion
Published: June 13, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026